These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 29800753)

  • 1. Analysis of HLA-B Allelic Variation and IFN-γ ELISpot Responses in Patients with Severe Cutaneous Adverse Reactions Associated with Drugs.
    Klaewsongkram J; Sukasem C; Thantiworasit P; Suthumchai N; Rerknimitr P; Tuchinda P; Chularojanamontri L; Srinoulprasert Y; Rerkpattanapipat T; Chanprapaph K; Disphanurat W; Chakkavittumrong P; Tovanabutra N; Srisuttiyakorn C;
    J Allergy Clin Immunol Pract; 2019 Jan; 7(1):219-227.e4. PubMed ID: 29800753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA Allele Frequencies in 5802 Koreans: Varied Allele Types Associated with SJS/TEN According to Culprit Drugs.
    Park HJ; Kim YJ; Kim DH; Kim J; Park KH; Park JW; Lee JH
    Yonsei Med J; 2016 Jan; 57(1):118-26. PubMed ID: 26632391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro test to confirm diagnosis of allopurinol-induced severe cutaneous adverse reactions.
    Klaewsongkram J; Thantiworasit P; Suthumchai N; Rerknimitr P; Sukasem C; Tuchinda P; Chularojanamontri L; Srinoulprasert Y; Rerkpattanapipat T; Chanprapaph K; Disphanurat W; Chakkavittumrong P; Tovanabutra N; Srisuttiyakorn C
    Br J Dermatol; 2016 Nov; 175(5):994-1002. PubMed ID: 27106261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous drug reactions to antiepileptic drugs and relation with HLA alleles in the Turkish population.
    Büyüköztürk S; Kekik Ç; Gökyiğit AZ; Tezer Filik FI; Karakaya G; Saygi S; Dursun AB; Kirbaş S; Tüfekçi A; Sin AZ; Aydoğdu I; Sorgun MH; Aydin N; Gelincik A; Çolakoğlu B; Çelik G; Oğuz F
    Eur Ann Allergy Clin Immunol; 2018 Jan; 50(1):36-41. PubMed ID: 29350020
    [No Abstract]   [Full Text] [Related]  

  • 5. The Presence of HLA-B75, DR13 Homozygosity, or DR14 Additionally Increases the Risk of Allopurinol-Induced Severe Cutaneous Adverse Reactions in HLA-B*58:01 Carriers.
    Shim JS; Yun J; Kim MY; Chung SJ; Oh JH; Kang DY; Jung JW; Cho SH; Kang HR
    J Allergy Clin Immunol Pract; 2019 Apr; 7(4):1261-1270. PubMed ID: 30529060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of
    Klaewsongkram J; Buranapraditkun S; Thantiworasit P; Rerknimitr P; Tuchinda P; Chularojanamontri L; Rerkpattanapipat T; Chanprapaph K; Disphanurat W; Chakkavittumrong P; Tovanabutra N; Srisuttiyakorn C; Srinoulprasert Y; Sukasem C; Chongpison Y
    Allergy Asthma Immunol Res; 2021 Nov; 13(6):896-907. PubMed ID: 34734507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic susceptibilities and prediction modeling of carbamazepine and allopurinol-induced severe cutaneous adverse reactions in Vietnamese.
    van Nguyen D; Chu HC; Vidal C; Fulton RB; Nguyen NN; Quynh Do NT; Tran TL; Nguyen TN; Thu Nguyen HT; Chu HH; Thanh Thuc HT; Minh Le HT; van Nunen S; Anderson J; Fernando SL
    Pharmacogenomics; 2021 Jan; 22(1):1-12. PubMed ID: 33356553
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug hypersensitivity: pharmacogenetics and clinical syndromes.
    Phillips EJ; Chung WH; Mockenhaupt M; Roujeau JC; Mallal SA
    J Allergy Clin Immunol; 2011 Mar; 127(3 Suppl):S60-6. PubMed ID: 21354501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of HLA genotypes with phenytoin induced severe cutaneous adverse drug reactions in Thai children.
    Manuyakorn W; Likkasittipan P; Wattanapokayakit S; Suvichapanich S; Inunchot W; Wichukchinda N; Khongkhatithuml C; Thampratankul L; Kamchaisatian W; Benjaponpitak S; Mahasirimongkol S
    Epilepsy Res; 2020 May; 162():106321. PubMed ID: 32272329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel interferon-γ enzyme-linked immunoSpot assay using activated cells for identifying hypersensitivity-inducing drug culprits.
    Kato K; Kawase A; Azukizawa H; Hanafusa T; Nakagawa Y; Murota H; Sakaguchi S; Asada H; Katayama I
    J Dermatol Sci; 2017 Jun; 86(3):222-229. PubMed ID: 28330775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetics and the potential for predictive tests in adverse drug reactions.
    Pirmohamed M
    Chem Immunol Allergy; 2012; 97():18-31. PubMed ID: 22613851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA-associated antiepileptic drug-induced cutaneous adverse reactions.
    Mullan KA; Anderson A; Illing PT; Kwan P; Purcell AW; Mifsud NA
    HLA; 2019 Jun; 93(6):417-435. PubMed ID: 30895730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between HLA-B Alleles and Carbamazepine-Induced Maculopapular Exanthema and Severe Cutaneous Reactions in Thai Patients.
    Sukasem C; Chaichan C; Nakkrut T; Satapornpong P; Jaruthamsophon K; Jantararoungtong T; Koomdee N; Sririttha S; Medhasi S; Oo-Puthinan S; Rerkpattanapipat T; Klaewsongkram J; Rerknimitr P; Tuchinda P; Chularojanamontri L; Tovanabutra N; Puangpetch A; Aekplakorn W
    J Immunol Res; 2018; 2018():2780272. PubMed ID: 29546073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between human leukocyte antigens and cutaneous adverse drug reactions to antiepileptics and antibiotics in the Iranian population.
    Mortazavi H; Rostami A; Firooz A; Esmaili N; Ghiasi M; Lajevardi V; Amirzargar AA; Sheykhi I; Khamesipour A; Akhdar M
    Dermatol Ther; 2022 May; 35(5):e15393. PubMed ID: 35187767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenobarbital-induced severe cutaneous adverse drug reactions are associated with CYP2C19*2 in Thai children.
    Manuyakorn W; Siripool K; Kamchaisatian W; Pakakasama S; Visudtibhan A; Vilaiyuk S; Rujirawat T; Benjaponpitak S
    Pediatr Allergy Immunol; 2013 May; 24(3):299-303. PubMed ID: 23551241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of the HLA-B(*)58:01 Allele and Renal Impairment on Allopurinol-Induced Cutaneous Adverse Reactions.
    Ng CY; Yeh YT; Wang CW; Hung SI; Yang CH; Chang YC; Chang WC; Lin YJ; Chang CJ; Su SC; Fan WL; Chen DY; Wu YJ; Tian YC; Hui RC; Chung WH;
    J Invest Dermatol; 2016 Jul; 136(7):1373-1381. PubMed ID: 26996548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of HLA genotypes with phenobarbital hypersensitivity in children.
    Manuyakorn W; Mahasirimongkol S; Likkasittipan P; Kamchaisatian W; Wattanapokayakit S; Inunchot W; Visudtibhan A; Wichukchinda N; Benjaponpitak S
    Epilepsia; 2016 Oct; 57(10):1610-1616. PubMed ID: 27554620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genotype-phenotype association between HLA and carbamazepine-induced hypersensitivity reactions: strength and clinical correlations.
    Hsiao YH; Hui RC; Wu T; Chang WC; Hsih MS; Yang CH; Ho HC; Chang YG; Chen MJ; Lin JY; Chen DP; Chang PY; Wu TL; Hung SI; Chung WH
    J Dermatol Sci; 2014 Feb; 73(2):101-9. PubMed ID: 24268988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of the HLA-B
    Park HW; Kim DK; Kim SH; Kim S; Chae DW; Yang MS; Oh YK; Lee JP; Jung JW; Shin J; Hwang JH; Kang MG; Kim SM; Kwon SK; Kim HY; Kim MH; Kim SJ; Ryu DR; Cho YJ; Jee YK; Kim SM; Lee EK; Kim JY; Cho HS; Jeong YY; Kim SH; Jun JB; Park JS; Kim GH; Kim S; Jung HY; Lee JM
    J Allergy Clin Immunol Pract; 2019 Apr; 7(4):1271-1276. PubMed ID: 30580048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe Cutaneous Adverse Drug Reactions in Pediatric Patients: A Multicenter Study.
    Dibek Misirlioglu E; Guvenir H; Bahceci S; Haktanir Abul M; Can D; Usta Guc BE; Erkocoğlu M; Toyran M; Nacaroglu HT; Civelek E; Buyuktiryaki B; Ginis T; Orhan F; Kocabas CN
    J Allergy Clin Immunol Pract; 2017; 5(3):757-763. PubMed ID: 28351788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.